Neuropathic pruritus

Nature Reviews Neurology

Volumn 10, Issue 7, 2014, Pages 408-416

  Misery, Laurent ^a   Brenaut, Emilie ^a   Le Garrec, Raphaële ^b   Abasq, Claire ^a   Genestet, Steeve ^a   Marcorelles, Pascale ^a   Zagnoli, Fabien ^c  

^a BREST UNIVERSITY HOSPITAL   (France)

^b FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^c Military Teaching Hospital Clermont Tonnerre   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIMALARIAL AGENT; APREPITANT; CAMPHOR; CAPSAICIN; CHLOROQUINE; CYCLOSPORIN A; GABAPENTIN; HERBACEOUS AGENT; HETASTARCH; LIDOCAINE; MENTHOL; MU OPIATE RECEPTOR; OPIATE; OPIATE ANTAGONIST; PALMIDROL; PIMECROLIMUS; PREGABALIN; TACROLIMUS; THALIDOMIDE; VANILLOID RECEPTOR 1 ANTAGONIST;

ACUPUNCTURE; BRACHIORADIAL PRURITUS; BRAIN DISEASE; BURN SCAR; CHRONIC PAIN; CIGUATERA; DEMYELINATING DISEASE; DRUG INDUCED DISEASE; ELECTROMYOGRAPHY; GANGLIONOPATHY; HUMAN; NERVE COMPRESSION; NERVE CONDUCTION; NEURALGIA; NEURODERMATITIS; NEUROPATHIC PAIN; NEUROPATHIC PRURITUS; NEUROPATHOLOGY; NEUROPATHY; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NEUROPATHY; PHOTOTHERAPY; POLYNEUROPATHY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; REVIEW; SKIN BIOPSY; SKIN SENSITIVITY; SMALL FIBER NEUROPATHY; SPINAL CORD DISEASE; TERATOGENICITY; THROMBOGENICITY; TRANSCUTANEOUS NERVE STIMULATION; CENTRAL NERVOUS SYSTEM; COMPLICATION; NEUROLOGIC DISEASE; PATHOLOGY;

CENTRAL NERVOUS SYSTEM; HUMANS; MAGNETIC RESONANCE IMAGING; NERVOUS SYSTEM DISEASES; PRURITUS;

EID: 84904038568     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2014.99     Document Type: Review

References (109)

1. Misery, L. & Stander, S. (Eds) Pruritus (Springer, 2010).
2. Yosipovitch, G., Greaves, M. W. & Schmelz, M. Itch. Lancet 361, 690-694 (2003).
3. Dalgard, F., Lien, L. & Dalen, I. Itch in the community: Associations with psychosocial factors among adults. J. Eur. Acad. Dermatol. Venereol. 21, 1215-1219 (2007).
4. Misery, L., Rahhali, N., Duhamel, A. & Taieb, C. Epidemiology of pruritus in France. Acta Derm. Venereol. 92, 541-542 (2012).
5. Halvorsen, J. A., Dalgard, F., Thoresen, M., Bjertness, E. & Lien, L. Itch and mental distress: A cross-sectional study among late adolescents. Acta Derm. Venereol. 89, 39-44 (2009).
6. Kini, S. P. et al. The impact of pruritus on quality of life: The skin equivalent of pain. Arch. Dermatol. 147, 1153-1156 (2011).
7. Baron, R., Binder, A. & Wasner, G. Neuropathic pain: Diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 9, 807-819 (2010).
8. Truini, A., Garcia-Larrea, L. & Cruccu, G. Reappraising neuropathic pain in humans-how symptoms help disclose mechanisms. Nat. Rev. Neurol. 9, 572-582 (2013).
9. Stumpf, A. & Ständer, S. Neuropathic itch: Diagnosis and management. Dermatol. Ther. 26, 104-109 (2013).
10. Oaklander, A. L. Neuropathic itch. Semin. Cutan. Med. Surg. 30, 87-92 (2011).
11. Oaklander, A. L. Common neuropathic itch syndromes. Acta Derm. Venereol. 92, 118-125 (2012).
12. Dhand, A. & Aminoff, M. J. The neurology of itch. Brain 137 313-322 (2013).
13. Binder, A., Koroschetz, J. & Baron, R. Disease mechanisms in neuropathic itch. Nat. Clin. Pract. Neurol. 4, 329-337 (2008).
14. Stander, S. et al. Clinical classification of itch: A position paper of the International Forum for the Study of Itch. Acta Derm. Venereol. 87, 291-294 (2007).
15. Yosipovitch, G. The pruritus receptor unit: A target for novel therapies. J. Invest. Dermatol. 127, 1857-1858 (2007).
16. Schmelz, M., Schmidt, D., Bickel, A., Handwerker, H. & Torebjörk, H. E. Specific C receptors for itch in human skin. J. Neurosci. 17, 8003-8008 (1997).
17. Schmelz, M. et al. Chemical response pattern of different classes of C nociceptors to pruritogens and algogens. J. Neurophysiol. 89, 2441-2448 (2003).
18. Ikoma, A., Steinhoff, M., Stander, S., Yosipovitch, G. & Schmelz, M. The neurobiology of itch. Nat. Rev. Neurosci. 7, 535-547 (2006).
19. Johanek, L. M. et al. A role for polymodal C fiber afferents in nonhistaminergic itch. J. Neurosci. 28, 7659-7669 (2008).
20. Steinhoff, M. et al. Proteinase-Activated receptor 2 mediates itch: A novel pathway for pruritus in human skin. J. Neurosci. 23, 6176-6180 (2003).
21. Sikand, P., Shimada, S. G., Green, B. G. & LaMotte, R. H. Sensory responses to injection and punctate application of capsaicin and histamine to the skin. Pain 152, 2485-2494 (2011).
22. Akiyama, T. & Carstens, E. Neural processing of itch. Neuroscience 250, 697-714 (2013).
23. Andrew, D. & Craig, A. D. Spinothalamic lamina I neurons selectively sensitive to histamine: A central neural pathway for itch. Nat. Neurosci. 4, 72-77 (2001).
24. Davidson, S. et al. The itch-producing agents histamine and cowhage activate separate populations of primate spinothalamic tract neurons. J. Neurosci. 27, 10007-10014 (2007).
25. Ross, S. E., et al. Loss of inhibitory interneurons in the dorsal spinal cord and elevated itch in Bhlhb5 mutant mice. Neuron 65, 886-898 (2010).
26. Lagerström, M. C. et al. VGLUT2-dependent sensory neurons in the TRPV1 population regulate pain and itch. Neuron 68, 529-542 (2010).
27. Davidson, S. et al. Pruriceptive spinothalamic tract neurons: Physiological properties and projection targets in the primate J. Neurophysiol. 108, 1711-1723 (2012).
28. Hsieh, J. C. et al. Urge to scratch represented in the human cerebral cortex during itch. J. Neurophysiol. 72, 3004-3008 (1994).
29. Papoiu, A. D., Coghill, R. C., Kraft, R. A., Wang, H. & Yosipovitch, G. A tale of two itches. Common features and notable differences in brain activation evoked by cowhage and histamine induced itch. NeuroImage 59, 3611-3623 (2012).
30. Valet, M. et al. Cerebral processing of histamine-induced itch using short-Term alternating temperature modulation-An fMRI study. J. Invest. Dermatol. 128, 426-433 (2007).
31. Yosipovitch, G. et al. The brain processing of scratching. J. Invest. Dermatol. 128, 1806-1811 (2008).
32. Mochizuki, H. et al. Cortico-subcortical activation patterns for itch and pain imagery. Pain 154, 1989-1998 (2013).
33. Cohen, O. S. et al. Pruritus in familial Creutzfeldt-Jakob disease: A common symptom associated with central nervous system pathology. J. Neurol. 258, 89-95 (2011).
34. Thielen, A. M., Vokatch, N. & Borradori, L. Chronic hemicorporal prurigo related to a post-Traumatic Brown-Séquard syndrome. Dermatology 217, 45-47 (2008).
35. Elsone, L. et al. Neuropathic pruritus (itch) in neuromyelitis optica. Mult. Scler. 19, 475-479 (2013).
36. Bouhassira, D. & Attal, N. Diagnosis and assessment of neuropathic pain: The saga of clinical tools. Pain 152 (Suppl. 3), S74-S83 (2011).
37. Serling, S. L., Leslie, K. & Maurer, T. Approach to pruritus in the adult HIV-positive patient. Semin. Cutan. Med. Surg. 30, 101-106 (2011).
38. Oaklander, A. L., Bowsher, D., Galer, B., Haanpää, M. & Jensen, M. P. Herpes zoster itch: Preliminary epidemiologic data. J. Pain 4, 338-343 (2003).
39. Ruocco, V., Sangiuliano, S., Brunetti, G. & Ruocco, E. Beyond zoster: Sensory and immune changes in zoster-Affected dermatomes: A review. Acta Derm. Venereol. 92, 378-382 (2012).
40. Oaklander, A. L. Mechanisms of pain and itch caused by herpes zoster (shingles). J. Pain 9 (Suppl. 1), S10-S18 (2008).
41. Nagel, M. A. & Gilden, D. The trigeminal trophic syndrome. Neurology 77, 1499 (2011).
42. Fleuret, C. et al. Brachioradial pruritus revealing an ependymoma [French]. Ann. Dermatol. Venereol. 136, 435-437 (2009).
43. Waisman, M. Solar pruritus of the elbows (brachioradial summer pruritus). Arch. Dermatol. 98, 481-485 (1968).
44. Marziniak, M. et al. Brachioradial pruritus as a result of cervical spine pathology: The results of a magnetic resonance tomography study. J. Am. Acad. Dermatol. 65, 756-762 (2011).
45. Kwatra, S. G., Stander, S., Bernhard, J. D., Weisshaar, E. & Yosipovitch, G. Brachioradial pruritus: A trigger for generalization of itch. J. Am. Acad. Dermatol. 68, 870-873 (2013).
46. Misery, L. What is notalgia paresthetica? Dermatology 204, 86-87 (2002).
47. Ellis, C. Notalgia paresthetica: The unreachable itch. Dermatol. Pract. Concept. 3, 3-6 (2013).
48. Savk, E. et al. Notalgia paresthetica: A study on pathogenesis. Int. J. Dermatol. 39, 754-759 (2000).
49. Streib, E. W. & Sun, S. F. Notalgia paresthetica owing to compression neuropathy: Case presentation including electrodiagnostic studies. Eur. Neurol. 20, 64-67 (1981).
50. Savk, O. & Savk, E. Investigation of spinal pathology in notalgia paresthetica. J. Am. Acad. Dermatol. 52, 1085-1087 (2005).
51. Huesmann, T. et al. Notalgia paraesthetica: A descriptive two-cohort study of 65 patients from Brazil and Germany. Acta Derm. Venereol. 92, 535-540 (2012).
52. Dong, Q. et al. Entrapment neuropathies in the upper and lower limbs: Anatomy and MRI features. Radiol Res. Pract. 2012, 230679 (2012).
53. Ehrlich, W., Dellon, A. L. & Mackinnon, S. E. Classical article: Cheiralgia paresthetica (entrapment of the radial nerve). A translation in condensed form of Robert Wartenberg's original article published in 1932. J. Hand Surg. Am. 11, 196-199 (1986).
54. Patijn, J. et al. Meralgia paresthetica. Pain Pract. 11, 302-308 (2011).
55. Labat, J. J. et al. Diagnostic criteria for pudendal neuralgia by pudendal nerve entrapment (Nantes criteria). Neurourol. Urodyn. 27, 306-310 (2008).
56. Misery, L., Bodéré, C., Genestet, S., Zagnoli, F. & Marcorelles, P. Small-fiber neuropathies and skin: News and perspectives for dermatologists. Eur. J. Dermatol. 24, 147-153 (2014).
57. McArthur, J. C. Painful small fiber neuropathies. Continuum (Minneap. Minn.) 18, 106-125 (2012).
58. Tavee, J. & Zhou, L. Small fiber neuropathy: A burning problem. Cleve. Clin. J. Med. 76, 297-305 (2009).
59. Lauria, G. et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur. J. Neurol. 17, 903-912, e44-e49 (2010).
60. Lauria, G. et al. Intraepidermal nerve fiber density at the distal leg: A worldwide normative reference study. J. Peripher. Nerv. Syst. 15, 202-207 (2010).
61. Devigili, G. et al. The diagnostic criteria for small fibre neuropathy: From symptoms to neuropathology. Brain 131, 1912-1925 (2008).
62. Schuhknecht, B. et al. Reduced intraepidermal nerve fibre density in lesional and nonlesional prurigo nodularis skin as a potential sign of subclinical cutaneous neuropathy. Br. J. Dermatol. 165, 85-91 (2011).
63. Chéret, J., Lebonvallet, N., Buhé, V., Misery, L. & Le Gall-Ianotto, C. Influence of neurotransmitters and NGF on human cutaneous wound healing process. Wound Repair Reg. 21, 772-788 (2013).
64. Lee, S. S., Yosipovitch, G., Chan, Y. H. & Goh, C. L. Pruritus, pain, and small nerve fiber function in keloids: A controlled study. J. Am. Acad. Dermatol. 51, 1002-1006 (2004).
65. Van Loey, N. E., Bremer, M., Faber, A. W., Middelkoop, E. & Nieuwenhuis, M. K. Itching following burns: Epidemiology and predictors. Br. J. Dermatol. 158, 95-100 (2008).
66. Goutos, I. Neuropathic mechanisms in the pathophysiology of burns pruritus: Redefining directions for therapy and research. J. Burn Care Res. 34, 82-93 (2013).
67. Berardesca, E., Fluhr, J. W. & Maibach, H. I. Sensitive Skin Syndrome. (Taylor & Francis, 2006).
68. Misery, L. Sensitive skin. Expert Rev. Dermatol. 8, 631-637 (2013).
69. Farage, M. A. & Maibach, H. I. Sensitive skin: Closing in on a physiological cause. Contact Dermatitis 62, 137-149 (2010).
70. Farage, M. A. How do perceptions fo sensitive skin differ at different anatomical sites? An epidemiological study. Clin. Exp. Dermatol. 34, 521-530 (2009).
71. Stander, S., Schneider, S. W., Weishaupt, C., Luger, T. A. & Misery, L. Putative neuronal mechanisms of sensitive skin. Exp. Dermatol. 18, 417-423 (2009).
72. Khosrotehrani, K. et al. Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: A cohort study of 703 patients. Am. J. Med. Genet. 132A, 49-53 (2005).
73. O'Brien, D. E., Brenner, D. S., Gutmann, D. H. & Gereau, R. W. Assessment of pain and itch behavior in a mouse model of neurofibromatosis type 1. J. Pain 14, 628-637 (2013).
74. Friedman, M. A. et al. Ciguatera fish poisoning: Treatment, prevention and management. Mar. Drugs 6, 458-479 (2008).
75. Pearn, J. Neurology of ciguatera. J. Neurol. Neurosurg. Psychiatry 70, 4-8 (2001).
76. Vetter, I. et al. Ciguatoxins activate specific cold pain pathways to elicit burning pain from cooling. EMBO J. 31, 3795-3808 (2012).
77. Boydron-Le Garrec, R. et al. Ability of some plant extracts, traditionally used to treat ciguatera fish poisoning, to prevent the in vitro neurotoxicity produced by sodium channel activators. Toxicon 46, 625-634 (2005).
78. Reich, A., Ständer, S. & Szepietowski, J. C. Drug-induced pruritus: A review. Acta Derm. Venereol. 89, 236-244 (2009).
79. Pereira, U. et al. Mechanisms of the sensory effects of tacrolimus on the skin. Br. J. Dermatol. 163, 70-77 (2010).
80. Bork, K. Pruritus precipitated by hydroxyethyl starch: A review. Br. J. Dermatol. 152, 3-12 (2005).
81. Liu, Q. et al. Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell 139, 1353-1365 (2009).
82. Biro, T. et al. How best to fight that nasty itch-from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches. Exp. Dermatol. 14, 225-240 (2005).
83. Bernhard, J. D. & Bordeaux, J. S. Medical pearl: The ice-pack sign in brachioradial pruritus. J. Am. Acad. Dermatol. 52, 1073 (2005).
84. Weisshaar, E. et al. European guideline on chronic pruritus. Acta Derm. Venereol. 92, 563-581 (2012).
85. Gupta, M. A., Gupta, A. K., Schork, N. J. & Ellis, C. N. Depression modulates pruritus perception: A study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom. Med. 56, 36-40 (1994).
86. Ständer, S. et al. Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: Results of an open-labelled, two-Arm proof of concept study. Acta Derm. Venereol. 89, 45-51 (2009).
87. Trevisani, M. & Szallasi, A. Targeting TRPV1: Challenges and issues in pain management. Open Drug Discov. J. 2, 37-49 (2010).
88. Szolcsanyi, J. Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptides 38, 377-384 (2004).
89. Wallengren, J. & Klinker, M. Successful treatment of notalgia paresthetica with topical capsaicin: Vehicle-controlled, double-blind, crossover study. J. Am. Acad. Dermatol. 32, 287-289 (1995).
90. Wallengren, J. Brachioradial pruritus: A recurrent solar dermopathy. J. Am. Acad. Dermatol. 39, 803-806 (1998).
91. Webster, L. R. et al. Tolerability of NGX 4010, a capsaicin 8% dermal patch, following pretreatment with lidocaine 2.5%/prilocaine 2.5% cream in patients with post-herpetic neuralgia. BMC Anesthesiol. 11, 25 (2011).
92. Baranidharan, G., Das, S. & Bhaskar, A. A review of the high-concentration capsaicin patch and experience in its use in the management of neuropathic pain. Ther. Adv. Neurol. Disord. 6, 287-297 (2013).
93. Phan, N. Q., Siepmann, D., Gralow, I. & Ständer, S. Adjuvant topical therapy with a cannabinoid receptor agonist in facial postherpetic neuralgia. J. Dtsch Dermatol. Ges. 8, 88-91 (2010).
94. Misery, L. Gabapentin in dermatology. Dermatology 211, 79-80 (2005).
95. Argoff, C. E., Katz, N. & Backonja, M. Treatment of postherpetic neuralgia: A review of therapeutic options. J. Pain Symptom Manage. 28, 396-411 (2004).
96. Kanitakis, J. Brachioradial pruritus: Report of a new case responding to gabapentin. Eur. J. Dermatol. 16, 311-312 (2006).
97. Mendham, J. E. Gabapentin for the treatment of itching produced by burns and wound healing in children: A pilot study. Burns 30, 851-853 (2004).
98. Perez, C. M., Vasquez, P. A. & Perret, C. F. Treatment of ciguatera poisoning with gabapentin. N. Engl. J. Med. 344, 692-693 (2001).
99. Ferrandiz, C., Carrascosa, J. M., Just, M., Bielsa, I. & Ribera, M. Sequential combined therapy with thalidomide and narrow-band (TL01) UVB in the treatment of prurigo nodularis. Dermatology 195, 359-361 (1997).
100. Maurer, T., Poncelet, A. & Berger, T. Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects. Arch. Dermatol. 140, 845-849 (2004).
101. Ständer, S., Siepmann, D., Herrgott, I., Sunderkotter, C. & Luger, T. A. Targeting the neurokinin receptor 1 with aprepitant: A novel antipruritic strategy. PLoS ONE 5, e10968 (2010).
102. Akhtar, N. & Brooks, P. The use of botulinum toxin in the management of burns itching: Preliminary results. Burns 38, 1119-1123 (2012).
103. Wallengren, J. & Bartosik, J. Botulinum toxin type A for neuropathic itch. Br. J. Dermatol. 163, 424-426 (2010).
104. Carlsson, C. P., Sundler, F. & Wallengren, J. Cutaneous innervation before and after one treatment period of acupuncture. Br. J. Dermatol. 155, 970-976 (2006).
105. Stellon, A. Neurogenic pruritus: An unrecognised problem? A retrospective case series of treatment by acupuncture. Acupunct. Med. 20, 186-190 (2002).
106. Pfab, F. et al. Acupuncture compared with oral antihistamine for type I hypersensitivity itch and skin response in adults with atopic dermatitis: A patient-And examiner-blinded, randomized, placebo-controlled, crossover trial. Allergy 67, 566-573 (2012).
107. Wallengren, J. & Sundler, F. Cutaneous field stimulation in the treatment of severe itch. Arch. Dermatol. 137, 1323-1325 (2001).
108. Knotkova, H., Portenoy, R. K. & Cruciani, R. A. Transcranial direct current stimulation (tDCS) relieved itching in a patient with chronic neuropathic pain. Clin. J. Pain 29, 621-622 (2013).
109. Sun, Y. G. & Chen, Z. F. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature 448, 700-703 (2007).